2021-Beyrend et al-preprint
"OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum"
Guillaume Beyrend, Tetje C. van der Sluis, Esmé T.I. van der Gracht, Tamim Abdelaal, Simon P. Jochems, Robert A. Belderbos, Thomas H. Wesselink, Suzanne van Duikeren, Floortje J. van Haften, Anke Redeker, Elham Beyranvand Nejad, Marcel Camps, Kees LMC Franken, Margot M. Linssen, Peter Hohenstein, Noel F.C.C. de Miranda, Hailiang Mei, Adriaan D. Bins, John B.A.G. Haanen, Joachim G. Aerts, Ferry Ossendorp, Ramon Arens
bioRxiv, posted December 25, 2021
https://doi.org/10.1101/2021.12.24.474145
- will update when/if this is peer-reviewed and published
- no dataset accession given
Guillaume Beyrend, Tetje C. van der Sluis, Esmé T.I. van der Gracht, Tamim Abdelaal, Simon P. Jochems, Robert A. Belderbos, Thomas H. Wesselink, Suzanne van Duikeren, Floortje J. van Haften, Anke Redeker, Elham Beyranvand Nejad, Marcel Camps, Kees LMC Franken, Margot M. Linssen, Peter Hohenstein, Noel F.C.C. de Miranda, Hailiang Mei, Adriaan D. Bins, John B.A.G. Haanen, Joachim G. Aerts, Ferry Ossendorp, Ramon Arens
bioRxiv, posted December 25, 2021
https://doi.org/10.1101/2021.12.24.474145
- will update when/if this is peer-reviewed and published
- no dataset accession given